Skip to main content
SpringerLink
Log in

Hormonal Contraception

  • Reference work entry
  • First Online:
Female Reproductive Dysfunction

Part of the book series: Endocrinology ((ENDOCR))

  • 706 Accesses

Abstract

The clinical approach to hormonal contraception is based on the integration of two points of view. On the one side we have to consider the specific needs and the biological characteristics of the girl or the woman asking for contraception, according to age, period of life, and personal physical or psychological vulnerability. On the other side, it is well documented that an appropriate choice of the formulation, maybe including therapeutic effects, facilitates the long-term adhesion to the method. This competence requires a thorough knowledge of the pharmacology of single preparations. Therefore a part of this chapter is the revision of the characteristics of various hormonal components of contraceptives in use. To follow is a synthesis of main contraindications, in agreement with current guidelines, and of therapeutic indications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abrams LS, Skee DM, Natarajan J, Wong FA, Lasseter KC. Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants. Contraception. 2001;64(5):287–94.

    Article  CAS  PubMed  Google Scholar 

  • Ahire D, Sinha S, Brock B, Iyer R, Mandlekar S, Subramanian M. Metabolite identification, reaction phenotyping, and retrospective drug-drug interaction predictions of 17-deacetylnorgestimate, the active component of the oral contraceptive norgestimate. Drug Metab Dispos. 2017;45:676–85.

    Article  CAS  PubMed  Google Scholar 

  • Algorta J, Diaz M, de Benito R, Lefebvre M, Sicard E, et al. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ ethinylestradiol 11.7/2.7 mg). Contraception. 2013;87:264–72.

    Article  CAS  Google Scholar 

  • André G. Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate. J Gynecol Obstet Biol Reprod (Paris). 2005;34(1 Pt 1):69–84.

    Article  Google Scholar 

  • Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril. 2014;101(6):1656–62.

    Article  CAS  PubMed  Google Scholar 

  • Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, et al. Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control. Eur J Contracept Reprod Health Care. 2017;22(4):260–7.

    Article  CAS  PubMed  Google Scholar 

  • Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;11(7):CD004425.

    Google Scholar 

  • Bateson D, Butcher BE, Donovan C, Farrell L, Kovacs G, et al. Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis. Aust Fam Physician. 2016;45(1):59–64.

    PubMed  Google Scholar 

  • Boozalis A, Tutlam NT, Robbins CC, Peipert JF. Sexual desire and hormonal contraception. Obstet Gynecol. 2016;127(3):563–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Byrne G. Prevalence and psychological sequelae of sexual abuse among individuals with an intellectual disability: a review of the recent literature. J Intellect Disabil. 2018;22(3):294–310.

    Article  PubMed  Google Scholar 

  • Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A. Route of administration of contraceptives containing desogestrel/etonogestrel and insulin sensitivity: a prospective randomized study. Contraception. 2009;80(1):34–9.

    Article  CAS  PubMed  Google Scholar 

  • Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, et al. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology. 2011;152(1):113–25.

    Article  CAS  PubMed  Google Scholar 

  • Chang T, Davis MM, Kusunoki Y, Ela E, Hall KS, Barber JS. Sexual behavior and contraceptive use among 18 to 19 year old adolescent women by weight status: a longitudinal analysis. J Pediatr. 2015;167(3):586–92.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen S, Kumar N, Mao Z, Sitruk-Ware R, Diaz Brinton R. Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain. Menopause. 2018;25(10):1138–51.

    Article  PubMed  Google Scholar 

  • Choi YS, Cho S, Lim KJ, Jeon YE, Yang HI, et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis. Growth Factors. 2010;28(6):452–60.

    Article  CAS  PubMed  Google Scholar 

  • Collaborative Study Group on the Desogestrel-containing Progestin only Pill. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Eur J Contracept Reprod Health Care. 1998;3(4):169–78.

    Article  Google Scholar 

  • Cortessis VK, Barrett M, Brown Wade N, Enebish T, et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstet Gynecol. 2017;130(6):1226–36.

    Article  PubMed  Google Scholar 

  • Darlympe J, Booth J, Flowers P, Lorimer K. Psychosocial factors influencing risk-taking in middle age for STIs. Sex Transm Infect. 2017;93(1):32–8.

    Article  Google Scholar 

  • De Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;3(3):CD010813.

    Google Scholar 

  • De Seta F, Restaino S, De Santo D, Stabile G, Banco R, Busetti M, et al. Effects of hormonal contraception on vaginal flora. Contraception. 2012;86(5):526–9.

    Article  PubMed  CAS  Google Scholar 

  • Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dei M, Bruni V. Guida alla ginecologia dell’infanzia e adolescenza, cap. 20 Ed. Firenze: OEO; 2016.

    Google Scholar 

  • Dinger J, Do Minh T, Heinemann K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception. 2016;94(4):328–39.

    Article  CAS  PubMed  Google Scholar 

  • Duijkers IJM, Hger-Mahn D, Drouin D, Colli E, Skouby S. Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake. Contraception. 2016;93(4):303–9.

    Article  CAS  PubMed  Google Scholar 

  • Engemise SL, Willets JM, Taylor AH, Emembolu JO, Konje JC. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):101–6.

    Article  CAS  PubMed  Google Scholar 

  • Fruzzetti F, Bitzer J. Review of clinical experience with estradiol in combined oral contraceptives. Contraception. 2010;81:8–15.

    Article  CAS  PubMed  Google Scholar 

  • Gaber TA. Significant reduction of the risk of venous thromboembolism in all long-term immobile patients a few months after the onset of immobility. Med Hypotheses. 2005;64(6):1173–6.

    Article  PubMed  Google Scholar 

  • Glisic M, Shahzad S, Tsoli S, Chadni M, et al. Association between progestin-only contraceptive use and cardiometabolic outcomes. A systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25(10):1042–52.

    Article  PubMed  PubMed Central  Google Scholar 

  • Goshtazebi A, Subotic Brajic T, Scholes D, Lederer Goldberg TB, Berenson A, Prior JC. Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies. Clin Endocrinol. 2019;90:517–24.

    Article  CAS  Google Scholar 

  • Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care. 2008;13:4–12.

    Article  CAS  PubMed  Google Scholar 

  • Grandi G, Cagnacci A, Volpe A. Pharmacokinetic evaluation of desogestrel as a female contraceptive. Expert Opin Drug Metab Toxicol. 2014a;10(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  • Grandi G, Piacenti I, Volpe A, Cagnacci A. Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol. Gynecol Endocrinol. 2014b;30(9):676–80.

    Article  CAS  PubMed  Google Scholar 

  • Hanjalic-Beck A, Schäfer WR, Deppert WR, Fischer L, Stein A, et al. Chlormadinone acetate suppresses prostaglandin biosynthesis in human endometrial explants. Fertil Steril. 2012;98(4):1017–22.

    Article  CAS  PubMed  Google Scholar 

  • Hardman SM, Gebbie AE. The contraception needs of the perimenopausal woman. Best Pract Res Clin Obst Gyn. 2014;28:903–15.

    Article  Google Scholar 

  • Hillard PJ. Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay. J Pediatr Adolesc Gynecol. 2012;25(5):308–13.

    Article  PubMed  Google Scholar 

  • Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, et al. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015;147:103–1.

    Article  CAS  PubMed  Google Scholar 

  • Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, et al. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study. Am J Obstet Gynecol. 2017;216(6):580 e1–9.

    Article  CAS  Google Scholar 

  • Jareid M, Thalabard JC, Aarflot M, Bovelstad HM, et al. Levonorgestrel-releasing Intrauterine System use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecol Oncol. 2018;149(1):127–32.

    Article  CAS  PubMed  Google Scholar 

  • Jatloui TC, Whiteman MK, Jeng G, Tepper NK, et al. Intrauterine device expulsion after postpartum placement: a systematic review and meta-analysis. Contraception. 2018;132:895–905.

    Google Scholar 

  • Johanesson U, Sahlin L, Masironi B, Hilliges M, Blomgren B. Steroid receptor expression and morphology in provoked vestibulodynia. Am J Obstet Gynecol. 2008;198(3):311.e1–6.

    Article  CAS  Google Scholar 

  • Kluft C, Zimmerman Y, Mawet M, Klipping C, et al. Reduced hemostatic effects with drospirenone -based oral contraceptives containing estetrol vs. ethinyl estradiol. Contraception. 2016;95(2):140–7.

    Article  PubMed  CAS  Google Scholar 

  • Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol. 2008;68(5):800–5.

    Article  CAS  Google Scholar 

  • Lenzi E, Pluchino N, Begliuomini S, Ninni F, Freschi L, et al. Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. J Steroid Biochem Mol Biol. 2008;110(1–2):67–75.

    Article  CAS  PubMed  Google Scholar 

  • Lete I, Lapuente O. Contraceptive options for women with premenstrual dysphoric disorders: current insights and a narrative review. Open Access J Contracept. 2016;7:117–25.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lethaby A, Wise MR, Weterings MA, Bofil Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:CD000154.

    PubMed  Google Scholar 

  • Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890–4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66.

    Article  CAS  PubMed  Google Scholar 

  • Lopez JM, Chen M, Mullins S, et al. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev. 2012;8:CD009849.

    Google Scholar 

  • Louw-du Toit R, Perkins MS, Snoep JL, Storbeck KH, Africander D. Fourth-generation progestins inhibit 3β-Hydroxysteroid dehydrogenase type 2 and modulate the biosynthesis of endogenous steroids. PLoS One. 2016;11(10):e0164170.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Martínez F, Ramírez I, Pérez-Campos E, Latorre K, Lete I. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2012;17(1):7–29.

    Article  PubMed  CAS  Google Scholar 

  • Maxwell L, Devries K, Zionts D, Alhusen JL, et al. Estimating the effect of intimate partner violence on women’s use of contraception: a systematic review and mea-analysis. PLoS One. 2015;10(2):e0118234.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meresman GF, Augé L, Barañao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77:1141–7.

    Article  PubMed  Google Scholar 

  • Merki-Feld GS, Apter D, Bartfai G, Grandi G, Haldre K, et al. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives. Eur J Contracept Reprod Health Care. 2017;22(4):247–9.

    Article  CAS  PubMed  Google Scholar 

  • Milanes-Skopp R, Nelson AL. Transdermal contraceptive patches: current status and future potential. Expert Rev Clin Pharmacol. 2009;2(6):601–7.

    Article  PubMed  Google Scholar 

  • MMWR. US Medical eligibility criteria for contraceptive use. Recomm Rep. 2016;65:3. www.cdc.gov/MMWR

  • Nappi ER, Kaunitz AM, Bitzer J. Extended regimen combined oral contraception: a review of evolving concepts and acceptance by women and clinicians. Eur J Contracept Reprod Health Care. 2016;21(2):106–15.

    Article  CAS  PubMed  Google Scholar 

  • Noboa S, Le Gal G, Lacut K, Mercier B, Leroyer C, EDITH Collaborative Study Group, et al. Family history as a risk factor for venous thromboembolism. Thromb Res. 2008;122(5):624–9.

    Article  CAS  PubMed  Google Scholar 

  • Oelkers W. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur J Contracept Reprod Health Care. 2002;7(Suppl 3):19–26.

    CAS  PubMed  Google Scholar 

  • Paris F, Balaguer P, Rimbault F, Gaspari L, Sultan C. Molecular actions of norgestimate: new developments. Gynecol Endocrinol. 2015;31(6):487–90.

    Article  CAS  PubMed  Google Scholar 

  • Pecchioli Y, Oyewumi L, Allen LM, Kives S. The utility of routine ultrasound in the diagnosis and management of adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol. 2017;30(2):239–42.

    Article  PubMed  Google Scholar 

  • Pluchino N, Lenzi E, Merlini S, Giannini A, Cubeddu A, et al. Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content. Contraception. 2009;80(1):53–62.

    Article  CAS  PubMed  Google Scholar 

  • Quint EH, O’Brien RF. Menstrual management for adolescents with disabilities. Pediatrics. 2016;138(1):e20160295.

    Article  PubMed  Google Scholar 

  • Raps M, Helmerhost F, Fleischer K, Thomassen S, Rosendaal F, et al. Sex hormone binding globulin as a marker for the thrombotic risk of hormonal contraceptives. J Thromb Haemost. 2012;10(6):992–8.

    Article  CAS  PubMed  Google Scholar 

  • Regidor PA, Colli E, Schidler AE. Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day. Gynecol Endocrinol. 2016;32(9):749–51.

    Article  CAS  PubMed  Google Scholar 

  • Riggs M, Klebanoff M, Nansel T, Zhang J, Schwebke J, Adrews W. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis. 2007;34(12):954–9.

    CAS  PubMed  Google Scholar 

  • Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015;8:CD011054.

    Google Scholar 

  • Rutanen EM. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Hum Reprod. 2000;15(Suppl 3):173–81.

    Article  CAS  PubMed  Google Scholar 

  • Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JT, et al. Classification and pharmacology of progestins. Maturitas. 2003;46(S1):S7–S16.

    Article  CAS  PubMed  Google Scholar 

  • Silverman JG, Mc Cauley HL, Decker MR, Miller E, Reed E, Raj A. Coercive forms of sexual risk and associated violence perpetrated by male partners of female adolescents. Perspect Sex Reprod Health. 2011;43(1):60–5.

    Article  PubMed  Google Scholar 

  • Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006;12(2):169–78.

    Article  CAS  PubMed  Google Scholar 

  • Stanczyk FZ, Archer DF. Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception. 2014;89(4):242–52.

    Article  CAS  PubMed  Google Scholar 

  • Stegeman BH, de Bastos M, Rosendaal FR l FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:f5298.

    Article  PubMed  PubMed Central  Google Scholar 

  • TepperNK BSL, Whiteman MK, Monsour M, et al. Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol. 2014;123(5):987–96.

    Article  Google Scholar 

  • Tosti C, Biscione A, Morgante G, Bifulco G, Luisi S, Petraglia F. Hormonal therapy for endometriosis: from molecular research to bedside. Eur J Obstet Gtnecol Reprod Biol. 2017;209:61–6.

    Article  CAS  Google Scholar 

  • Trémollieres F1. Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol? Gynecol Obstet Fertil. 2012;40(2):109–15.

    Article  Google Scholar 

  • UK Medical Eligibility Criteria. 2016. www.fsrh.org/ukmec

  • WHO. Medical eligibility criteria for contraceptive use. 2015. www.who.int/reproductivehealth/publications/MEC

  • Widman L, Choukas- Bradley S, Noar SM, Nesi J, HìGarrett MA. Parent- adolescent sexual communication and adolescent safer sex behavior: a meta-analysis. JAMA Pediatr. 2016;170(1):52–61.

    Article  PubMed  PubMed Central  Google Scholar 

  • Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012;120:21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yamamoto T, Yoshiji S, Yasuda J, Shiroshita K, Kitawaki J, Fujii M, Urabe M, et al. Aromatization of norethindrone in ethinylestradiol in human adult liver. Endocrinol Jpn. 1986;33(4):527–31.

    Article  CAS  PubMed  Google Scholar 

  • Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol. 2017;216(5):443–50.

    Article  CAS  PubMed  Google Scholar 

  • Zoller B, Li X, Sundquist J, Sundquist K. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation. 2011;124:1012–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Florence, Florence, Italy

    Vincenzina Bruni

  2. Italian Society Pediatric Adolescent Gynecology, Florence, Italy

    Metella Dei

  3. Pediatric and Adolescent Gynecology Unit Careggi Hospital Florence, Florence, Italy

    Francesca Pampaloni

Authors
  1. Vincenzina Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Metella Dei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Pampaloni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincenzina Bruni .

Editor information

Editors and Affiliations

  1. Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Firenze, Italy

    Felice Petraglia

  2. Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, University of Utrech, Utrecht, The Netherlands

    Bart C. Fauser

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Bruni, V., Dei, M., Pampaloni, F. (2020). Hormonal Contraception. In: Petraglia, F., Fauser, B. (eds) Female Reproductive Dysfunction . Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-14782-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-14782-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-14781-5

  • Online ISBN: 978-3-030-14782-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation